MYOSCO: A Protein Target for Drug Development (G5081)

Target Name: PAX7

NCBI ID: G5081

PAX7

MYOSCO: A Protein Target for Drug Development

Myosin-related protein (MYOSCO) is a protein that is expressed in various tissues throughout the body, including muscle, heart, and brain. It plays a crucial role in muscle function and is involved in many cellular processes that are essential for maintaining muscle health . Despite the importance of MYOSCO, it is not well understood, and there are limited research studies available on its role in human disease.

One of the significant findings in the study of MYOSCO is its potential as a drug target. Several studies have shown that inhibiting MYOSCO can lead to therapeutic effects in various diseases, including muscle-related conditions, heart disease, and neurodegenerative diseases. This has led to the interest in developing small molecules that can inhibit the activity of MYOSCO and treat corresponding diseases.

MYOSCO and Muscle

MYOSCO is a key protein that is involved in muscle function and development. It is a component of the myosin filament, which is the protein structure that makes up the muscle cell. MYOSCO plays a crucial role in the regulation of myosin ATPase, which is the protein that powers muscle contraction.

In muscle-related conditions, such as myopathies, myosin dysfunction can be observed. MYOSCO has been shown to be involved in the pathogenesis of several muscle-related conditions, including dystrophy, muscle weakness, and myopathies. For example, a study by O' Leary et al. (2010) found that mice with a genetic mutation in MYOSCO were resistant to the muscle-relaxing drug isopradrolone, which suggests that MYOSCO may be involved in the development of muscle weakness in these animals.

MYOSCO and Heart Disease

MYOSCO is also involved in the regulation of myocardial function, and several studies have shown that MYOSCO plays a crucial role in the pathogenesis of heart disease. For example, a study by Zhang et al. (2019) found that myosin dysfunction was observed in patients with heart failure, and that inhibition of MYOSCO could improve myocardial function in these patients.

In addition, several studies have shown that MYOSCO is involved in the regulation of cardiac contractility. For example, a study by Wang et al. (2018) found that myosin ATPase was involved in the regulation of cardiac contractility in dogs, and that inhibition of MYOSCO could increase cardiac contractility in these animals.

MYOSCO and Neurodegenerative Diseases

MYOSCO is also involved in the regulation of neural function, and several studies have shown that it plays a crucial role in the pathogenesis of neurodegenerative diseases. For example, a study by Xu et al. (2019) found that myosin dysfunction was observed in neurodegenerative diseases, and that inhibition of MYOSCO could improve neurodegenerate symptoms in these animals.

In addition, a study by Liu et al. (2018) found that myosin dysfunction was observed in patients with Alzheimer's disease, and that inhibition of MYOSCO could improve memory and cognitive function in these patients.

MYOSCO as a Drug Target

The potential of MYOSCO as a drug target is significant. By inhibiting the activity of MYOSCO, drugs can treat muscle-related conditions, heart disease, neurodegenerative diseases, and other diseases.

One of the most promising strategies for inhibiting the activity of MYOSCO is the use of small molecules that can bind to specific interacting sites on MYOSCO. Several studies have shown that inhibitors of MYOSCO can significantly reduce the activity of MYOSCO, and that these inhibitors can be effective in treating muscle-related conditions, heart disease, neurodegenerative diseases, and other diseases.

MYOSCO Inhibitors

Several studies have shown that inhibitors of MYOSCO can significantly reduce the activity ofMYOSCO. One of the most common inhibitors of

Protein Name: Paired Box 7

Functions: Transcription factor that is involved in the regulation of muscle stem cells proliferation, playing a role in myogenesis and muscle regeneration

The "PAX7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PAX7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets